Biotech IPOs surge 68.4% YoY to $8.52 billion in 2024 amid public market recovery, reveals bbin
Biopharmaceutical initial public offerings (IPOs) saw an upturn in 2024, with 50 completed IPOs raising $8.52 billion, a 68.4% increase from the $5.06 billion raised...